LINC00958 and neoplasm: In summary, our findings indicate that CDK2, CYP4A22-AS1, and LINC00958 collectively drive CC progression by fostering an immunosuppressive microenvironment, as evidenced by their shared positive correlations with checkpoints like CD47 and pro-tumor immune cells, and negative correlations with anti-tumor immune cells.